Which Mind-Body Practices May Lower Blood Pressure?

Mind-body therapy for high blood pressure has moved beyond the vague claim that "relaxation helps." Two 2026 network meta-analyses tried to compare specific practices instead of pooling them under labels such as yoga or qigong. That is useful progress. It does not yet tell us, with confidence, that one breathing technique beats every other option.

The most detailed analysis separated 11 interventions: Bhramari Pranayama (humming breath), Nadi Shodhana (alternate-nostril breathing), Sheetali, Trataka, composite yoga breathing, sound-based relaxation meditation, non-sound relaxation meditation, specific qigong, composite qigong, tai chi, and control care. Its published conclusions reportedly rank some practices for systolic and diastolic blood pressure, but the accessible text does not provide the actual effect sizes, SUCRA values, credible intervals, or certainty ratings. Without those numbers, naming a winner would be theater dressed as precision.

The defensible conclusion is narrower: subtype matters enough to study, but the current hierarchy remains probabilistic and fragile.

Why splitting up "mind-body therapy" matters

A 2026 network meta-analysis by Cui et al. included 15 randomized controlled trials with 949 people who had essential hypertension. Rather than treating all breathing exercises or all meditative movement as interchangeable, the authors built an 11-node comparison network and ranked interventions separately for systolic blood pressure (SBP) and diastolic blood pressure (DBP).

That design addresses a real problem. "Yoga" can mean humming exhalations, slow breathing, postures, a mixed class, meditation, or some combination of them. "Qigong" can also cover distinct routines with different movement intensity, supervision, and session lengths. Pooling such practices can produce a tidy average that answers a mushy question.

Network meta-analysis can estimate comparisons that few trials tested directly. If one trial compares Bhramari with usual care and another compares tai chi with usual care, the model can estimate Bhramari versus tai chi indirectly. SUCRA rankings then estimate each treatment's probability of placing near the top. They are rankings, not proof that the first-ranked practice produces a clinically meaningful advantage over the third-ranked practice.

In this case, that distinction matters. Fifteen trials divided across 11 active-treatment nodes and a control condition leave a sparse network. Many comparisons must travel through indirect evidence chains. A high rank can shift when one small trial enters or leaves the network, especially if credible intervals overlap. Rankings make nice headlines; uncertainty decides whether they deserve them.

The larger Chinese movement literature offers breadth, not a final answer

A separate 2026 network meta-analysis by Han et al. examined 48 randomized controlled trials of six traditional Chinese mind-body exercise therapies in middle-aged and older adults with hypertension. The study evaluated vascular health and cardiac-function outcomes, not simply office blood pressure.

The larger trial count makes this literature more substantial than the 15-trial network, and it supports studying tai chi, Baduanjin, and related qigong practices as distinct interventions. It also points toward outcomes that could matter biologically, such as vascular and cardiac measures. But those measures remain intermediate outcomes, not evidence that a practice prevents strokes, heart attacks, kidney disease, or death.

The published abstract does not supply the individual-form effect sizes, intervention schedules, risk-of-bias assessments, or rankings. It therefore cannot establish which Chinese practice works best, how often someone should train, or whether a small difference between forms is statistically reliable. "Forty-eight trials" is a meaningful number; it is not a substitute for seeing the results.

What the current evidence can and cannot support

The evidence supports mind-body practice as an adjunct to standard hypertension care, not as a medication replacement. The trials in these analyses used these practices alongside usual treatment. They do not compare humming breath, tai chi, or qigong against antihypertensive medication as competing therapies.

They also apply to essential hypertension. They do not establish treatment for secondary hypertension, hypertensive urgency, or hypertensive emergency. Anyone with severely elevated readings or symptoms such as chest pain, severe headache, weakness, confusion, or shortness of breath needs medical assessment, not a longer exhale.

Session dose remains uncertain at the subtype level. The included studies varied in frequency, duration, and supervision. The broad practical range often seen across these programs—20 to 60 minutes, three to five times weekly—describes structured practice, not a validated minimum dose for a particular technique. A person should not assume that a few unsupervised minutes once a week reproduce a supervised trial.

The methodological catches are not minor

Cui et al. used post-intervention blood pressure values rather than change from baseline because trials reported change scores inconsistently. That choice can be reasonable when data are limited, but it assumes groups began at comparable blood pressure. Small randomized trials can miss that balance by chance. If a treatment node happens to include participants with lower starting pressure, its post-treatment result can look better for reasons unrelated to the practice.

The top-ranked breathing practices deserve even more caution. The available evidence does not allow a trial-by-trial review of Bhramari Pranayama studies measuring SBP and DBP as primary outcomes in people with diagnosed hypertension. Nor does it provide direct human evidence tying Bhramari to changes in heart-rate variability, baroreflex sensitivity, nasal nitric oxide, or muscle sympathetic nerve activity in this population. Slow breathing has plausible autonomic effects; plausibility is not a demonstrated mechanism.

Publication bias is another concern for qigong and tai chi research that draws heavily from Chinese-language databases. Positive results are more likely to reach publication in many clinical literatures. If that pattern affects these trials, pooled estimates can overstate benefit. Short study follow-up adds a separate limit: typical endpoints fall around 8 to 24 weeks, while long-term cardiovascular event reduction remains untested.

Subtype differences are credible; exact rankings are still provisional

Research outside hypertension gives a reason to take subtype comparisons seriously, without treating it as confirmation of a blood-pressure ranking. A 2025 network meta-analysis in chronic cardiopulmonary dyspnea compared yoga, tai chi, Baduanjin, Liuzijue, Yijinjing, qigong, Wuqinxi, and Buddhist walking meditation across 44 randomized trials involving 2,957 participants. It found different modality profiles in a different population and for different rehabilitation outcomes. That supports the method: lumping every mind-body exercise together can hide meaningful variation.

Two other network meta-analyses reach a similar methodological point in different populations. A 2025 review of 31 randomized trials in peri- and postmenopausal women found that exercise modality influenced sleep-quality results; its reported certainty varied by modality. A 2026 dose-response network meta-analysis in overweight and obese populations compared seven exercise modes for sleep quality and BMI and examined training dose. Neither study measures hypertension outcomes, so neither proves that a given practice lowers blood pressure more than another. They show why intervention labels and dose deserve attention.

For people with controlled essential hypertension who want a low-risk addition to treatment, a structured, enjoyable practice is a reasonable starting point. Tai chi and traditional Chinese exercise have the larger trial base by count in the current comparative literature. Specific pranayama techniques may eventually prove especially useful, but the published quantitative evidence needed to make that call has not been independently verified here.

Choose a practice you can perform regularly, keep taking prescribed medication unless your clinician changes it, and track home blood pressure with a validated cuff. If the numbers do not improve, the honest response is to adjust the treatment plan—not to promote the breathing exercise to a job it has not earned.